Thieler Law Corp, member of the Investor Attorney Network, is investigating whether members of the board of directors of Humana Inc (NYSE: HUM) acted responsibly on behalf of investors’ profitability in the planned $37 billion sale to Aetna Inc (NYSE: AET). 

On July 3, 2015, Humana Inc (NYSE: HUM) and Aetna Inc (NYSE: AET) announced that they had entered into a merger agreement. Under the terms of the merger agreement, Humana stockholders will receive $125.00 in cash and 0.8375 Aetna common shares for each Humana share. This is a value of approximately $230 per Humana share based on the closing price of Aetna common shares on July 2, 2015. 

Based in Louisville, KY, and incorporated in 1964, Humana Inc is a health and well-being company. The retail segment of the company offers Medicare, commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products directly to individuals. The group segment offers the same services and products as its retail segment but additionally offers administrative services only products, and health and wellness solutions directly to employer groups.  The healthcare services segment provides pharmacy, provider services, home based services, integrated behavioral health services, and predictive modeling and informatics services to its health plan members, as well as to third parties. 

The investigation focuses on whether NYSE: HUM investors received the highest price and whether the directors of Humana Inc acted in the best interest of Humana Inc company and its shareholders. 

If you purchased Humana Inc (NYSE: HUM) prior to July 3, 2015, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324. 

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185